The price of hydroxychloroquine jumped 32% in March after the White House touted it as a potential COVID-19 treatment, according to 46Brooklyn, but the drug price watchdog says that increase is not out of the ordinary for the drug, which prevents malaria and treats lupus. From February to March, pharmacy acquisition costs for hydroxychloroquine rose 9 cents per pill, from $0.27 to $0.36. CMS published the data May 19 in an update to the National Drug Acquisition Cost (NADAC) database,...